Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
155.00
+2.25 (1.47%)
At close: Aug 13, 2025, 4:00 PM
155.00
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:30 PM EDT
CRL Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for CRL stock ranges from a low of $140 to a high of $250. The average analyst price target of $186 forecasts a 20.00% increase in the stock price over the next year.
Price Target: $186.00 (+20.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 1 | 1 |
Hold | 14 | 14 | 13 | 13 | 10 | 10 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 15 | 15 | 15 | 15 | 14 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Evercore ISI Group | Evercore ISI Group | Buy Maintains $180 → $190 | Buy | Maintains | $180 → $190 | +22.58% | Aug 8, 2025 |
JP Morgan | JP Morgan | Hold Maintains $145 → $160 | Hold | Maintains | $145 → $160 | +3.23% | Aug 7, 2025 |
Barclays | Barclays | Hold Maintains $155 → $165 | Hold | Maintains | $155 → $165 | +6.45% | Aug 7, 2025 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $170 → $180 | Buy | Maintains | $170 → $180 | +16.13% | Jul 9, 2025 |
Citigroup | Citigroup | Hold → Strong Buy Upgrades $150 → $200 | Hold → Strong Buy | Upgrades | $150 → $200 | +29.03% | Jul 9, 2025 |
Financial Forecast
Revenue This Year
3.94B
from 4.05B
Decreased by -2.77%
Revenue Next Year
4.04B
from 3.94B
Increased by 2.49%
EPS This Year
9.70
from 0.20
Increased by 4,748.00%
EPS Next Year
10.36
from 9.70
Increased by 6.85%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.2B | 4.3B | 4.8B | ||
Avg | 3.9B | 4.0B | 4.2B | ||
Low | 3.8B | 3.8B | 3.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.1% | 9.3% | 18.7% | ||
Avg | -2.8% | 2.5% | 5.1% | ||
Low | -6.8% | -4.3% | -3.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.29 | 11.48 | 12.75 | ||
Avg | 9.70 | 10.36 | 11.32 | ||
Low | 9.11 | 8.89 | 10.05 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5,045.0% | 18.4% | 23.0% | ||
Avg | 4,748.0% | 6.9% | 9.3% | ||
Low | 4,457.0% | -8.3% | -3.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.